Before docs check your vitals, check theirs

By: Lauran Neergaard and Jennifer Agiesta

Americans consider insurance and a good bedside manner in choosing a doctor, but will that doctor provide high-quality care? A new poll shows that people don’t know how to determine that.Being licensed and likable doesn’t necessarily mean a doctor is up to date on best practices. But consumers aren’t sure how to uncover much more. Just 22 percent of those questioned are... READ MORE

Lifestyle changes may slow aging of cells

By: Elizabeth Fernandez

A small pilot study shows for the first time that changes in diet, exercise, stress management and social support may result in longer telomeres — the parts of chromosomes that affect aging.It is the first controlled trial to show that any intervention might lengthen telomeres over time.The study, published online in The Lancet Oncology, was conducted by scientists at UC San Francisco ... READ MORE

Feds diverge on proper use of painkillers

By: Matthew Perrone

How do you have a conversation about prescription drugs that provide critical pain relief to millions of Americans yet also cause more fatal overdoses than heroin and cocaine combined?The answer is: It depends.Different parts of the federal government describe the problem — and potential solutions — of abuse with Vicodin, OxyContin and other opioid drugs in different terms.The... READ MORE

Talk allays questions about sex after cancer

By: June Corrigan

Here in the U.S., at least, we’ve come a long way from a time when cancer was barely talked about, even behind closed doors. Now all kinds of awareness campaigns, fundraising events and support groups have made it easier to address issues that you or a loved one might face.Amid all the openness, though, there remains a topic many are still reluctant to discuss. That topic, of course,... READ MORE

Immune system therapy kills off cancers

By: Marilynn Marchione

Two years ago, Arrica Wallace was riddled with tumors from widely spread cervical cancer that the strongest chemotherapy and radiation could not beat back. Today, the Kansas mother shows no signs of the disease, and it was her own immune system that made it go away. The experimental approach that helped her is one of the newest frontiers in the rapidly advancing field of cancer... READ MORE

Common drug may cut Alzheimer’s risk

By: Beacon

Research shows a common antidepressant may reduce production of one of the chief suspects behind Alzheimer’s, offering a new avenue in the hunt for drugs to prevent the devastating brain disease.It’s far too early for anyone worried about dementia to try the drug citalopram, which sells as the brand Celexa — and comes with side effects.“This is not the great new... READ MORE